Fundraising Fox
Asclepii
Founded 2022 · 13 employees on LinkedIn · 3 known investors
Find your way into Asclepii
130 people in our graph share verified history with the Asclepii team — schools, employers, funds. One of them is your warm intro.
Daniel Katzmanunlockedknows Franco Kraiselburd · together at Asclepii (overlapped)
×11knows the team · via National Science Foundation
Asclepii makes Poseidon, an FDA-cleared nanosilver hydrogel wound dressing that maintains a moist wound environment and blocks microbes for topical wound management. It is used by clinicians such as podiatrists and nurses for chronic and everyday wound care.
Founders & leadership
Asclepii was founded in 2022 by Franco Kraiselburd.
FK
Franco KraiselburdFounder & CEOFranco Kraiselburd is a biomedical engineer who worked as a researcher at the Faculty of Medicine of the University of São Paulo and at the Skeletal Research Center studying mesenchymal stem cells and cancer. He is founder and CEO of Asclepii, which develops biomaterial scaffolds and wound care products.
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeed roundApr 2025
Zentynel Frontier Investments (lead), Capital Factory
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Asclepii do?
- Asclepii makes Poseidon, an FDA-cleared nanosilver hydrogel wound dressing that maintains a moist wound environment and blocks microbes for topical wound management. It is used by clinicians such as podiatrists and nurses for chronic and everyday wound care.
- Who founded Asclepii?
- Asclepii was founded by Franco Kraiselburd in 2022.
- Who are Asclepii's investors?
- Asclepii's investors include JumpStart Equity, Zentynel Frontier Investments, Capital Factory.